Illumina's Verinata Health Reports Expanded Test of Verifi for Option to Test for Fetal Aneuploidy in Twin Pregnancies
October 14, 2013 at 06:36 AM EDT
Illumina, Inc. (NASDAQ: ILMN ) today announced that Verinata Health, an Illumina company, will offer a new test option for its non-invasive verifi® prenatal test.^1 Physicians will now be able to use the verifi® prenatal test for women pregnant with twins through natural or assisted reproductive methods. The verifi® prenatal test for twins
